Abstract:Epstein-Barr virus (EBV) infection has been advocated as a prerequisite for developing multiple sclerosis (MS) and possibly the propagation of the disease. However, the precise mechanisms for such influences are still unclear. A large-scale study investigating the host genetics of EBV serology and related clinical manifestations, such as infectious mononucleosis (IM), may help us better understand the role of EBV in MS pathogenesis. This study evaluates the host genetic factors that influence serological response against EBV and history of IM and cross-evaluates them with MS risk and genetic susceptibility in the Swedish population. Plasma IgG antibody levels against EBV nuclear antigen-1 (EBNA-1, truncated=aa[325-641], peptide=aa[385-420]) and viral capsid antigen p18 (VCAp18) were measured using bead-based multiplex serology for 8744 MS cases and 7229 population-matched controls. The MS risk association for high/low EBV antibody levels and history of IM was compared to relevant clinical measures along with sex, age at sampling, and associated HLA allele variants. Genome-wide and HLA allele association analyses were also performed to identify genetic risk factors for EBV antibody response and IM history. Higher antibody levels against VCAp18 (OR=1.74, 95% CI=1.60-1.88) and EBNA-1, particularly the peptide (OR=3.13, 95% CI=2.93-3.35), were associated with an increased risk for MS. The risk increased with higher anti-EBNA-1 IgG levels up to twelve times the reference risk. We also identified several independent HLA haplotypes associated with EBV serology overlapping with known MS risk alleles (e.g., DRB1*15:01 ). Although there were several candidates, no variants outside the HLA region reached genome-wide significance. Cumulative HLA risk for anti-EBNA-1 IgG levels, particularly the peptide fragment, was strongly associated with MS. In contrast, the genetic risk for high anti-VCAp18 IgG levels was not as strongly associated with MS risk. IM history was not associated with class II HLA genes but negatively associated with A*02:01 , which is protective against MS. Our findings emphasize that the risk association between anti-EBNA-1 IgG levels and MS may be partly due to overlapping HLA associations. Additionally, the increasing MS risk with increasing anti-EBNA-1 levels would be consistent with a pathogenic role of the EBNA-1 immune response, perhaps through molecular mimicry. Given that high anti-EBNA-1 antibodies may reflect a poorly controlled T-cell defense against the virus, our findings would be consistent with DRB1*15:01 being a poor class II antigen in the immune defense against EBV. Lastly, the difference in genetic control of IM supports the independent roles of EBNA-1 and IM in MS susceptibility.

Elevated genetic risk for multiple sclerosis emerged in steppe pastoralist populations

The genetic origins of multiple sclerosis

Prehistoric events might explain European multiple sclerosis risk

Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

Ancient DNA ties modern diseases to ancestry

[New gene map for multiple sclerosis]

Ancestral risk modification for multiple sclerosis susceptibility detected across the Major Histocompatibility Complex in a multi-ethnic population

Ancient DNA reveals origins of multiple sclerosis in Europe

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

Locus for severity implicates CNS resilience in progression of multiple sclerosis

The Selection Landscape and Genetic Legacy of Ancient Eurasians

A Comprehensive Examination of the Role of Epigenetic Factors in Multiple Sclerosis

GWAS highlights the neuronal contribution to multiple sclerosis susceptibility

Evolution of cytokine production capacity in ancient and modern European populations

Gene-Based Tests of a Genome-Wide Association Study Dataset Highlight Novel Multiple Sclerosis Risk Genes

Multiple sclerosis as a protector?

137 ancient human genomes from across the Eurasian steppes

A Putative Vulnerability Locus to Multiple Sclerosis Maps to 5p14–p12 in a Region Syntenic to the Murine Locus Eae2

Whole Exome Sequencing in Multi-Incident Families Identifies Novel Candidate Genes for Multiple Sclerosis

Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis

Environmental factors and a risk for multiple sclerosis in the Altai Territory